CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
42.93
0%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.09
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Syneos Health Inc ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 42.93
Open* 42.93
1-Year Change* -9.92%
Day's Range* 42.93 - 42.94
52 wk Range 22.89-64.25
Average Volume (10 days) 1.17M
Average Volume (3 months) 28.46M
Market Cap 4.43B
P/E Ratio 61.85
Shares Outstanding 103.72M
Revenue 5.42B
EPS 0.69
Dividend (Yield %) N/A
Beta 1.58
Next Earnings Date Nov 2, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Sep 27, 2023 42.93 0.00 0.00% 42.93 42.94 42.93
Sep 26, 2023 42.93 0.22 0.52% 42.71 42.94 42.70
Sep 25, 2023 42.73 0.04 0.09% 42.69 42.75 42.69
Sep 22, 2023 42.68 -0.08 -0.19% 42.76 42.77 42.68
Sep 21, 2023 42.73 -0.01 -0.02% 42.74 42.74 42.71
Sep 20, 2023 42.75 -0.04 -0.09% 42.79 42.80 42.74
Sep 19, 2023 42.78 0.05 0.12% 42.73 42.78 42.73
Sep 18, 2023 42.74 0.03 0.07% 42.71 42.74 42.71
Sep 15, 2023 42.70 -0.03 -0.07% 42.73 42.78 42.70
Sep 14, 2023 42.73 0.01 0.02% 42.72 42.78 42.71
Sep 13, 2023 42.73 0.03 0.07% 42.70 42.76 42.70
Sep 12, 2023 42.70 -0.02 -0.05% 42.72 42.74 42.70
Sep 11, 2023 42.72 0.07 0.16% 42.65 42.72 42.65
Sep 8, 2023 42.66 -0.02 -0.05% 42.68 42.71 42.66
Sep 7, 2023 42.69 -0.02 -0.05% 42.71 42.73 42.69
Sep 6, 2023 42.72 0.02 0.05% 42.70 42.80 42.69
Sep 5, 2023 42.68 -0.01 -0.02% 42.69 42.70 42.56
Sep 1, 2023 42.66 0.08 0.19% 42.58 42.69 42.58
Aug 31, 2023 42.68 0.04 0.09% 42.64 42.68 42.61
Aug 30, 2023 42.64 0.08 0.19% 42.56 42.65 42.55

INC Research Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 5393.08 5212.97 4415.78 4675.81 4390.12
Revenue 5393.08 5212.97 4415.78 4675.81 4390.12
Cost of Revenue, Total 4138.82 3994.48 3398.14 3638.11 3434.31
Gross Profit 1254.27 1218.49 1017.64 1037.7 955.806
Total Operating Expense 4990.71 4827.3 4117.08 4427.67 4234.09
Selling/General/Admin. Expenses, Total 547.254 570.765 442.484 454.076 406.396
Depreciation / Amortization 247.179 235.625 222.352 242.465 273.685
Unusual Expense (Income) 57.458 26.428 54.104 93.015 119.696
Operating Income 402.375 385.668 298.695 248.149 156.029
Interest Income (Expense), Net Non-Operating -83.844 -73.453 -94.457 -145.297 -100.398
Other, Net -3.966 2.945 -0.58 -1.143 1.627
Net Income Before Taxes 314.565 315.16 203.658 101.709 57.258
Net Income After Taxes 266.497 234.831 192.787 131.258 23.058
Net Income Before Extra. Items 266.497 234.831 192.787 131.258 23.058
Net Income 266.497 234.831 192.787 131.258 24.284
Total Adjustments to Net Income
Income Available to Common Excl. Extra. Items 266.497 234.831 192.787 131.258 23.058
Income Available to Common Incl. Extra. Items 266.497 234.831 192.787 131.258 24.284
Diluted Net Income 266.497 234.831 192.787 131.258 24.284
Diluted Weighted Average Shares 103.477 105.065 105.465 105.005 104.701
Diluted EPS Excluding Extraordinary Items 2.57542 2.2351 1.82797 1.25002 0.22023
Diluted Normalized EPS 3.04585 2.42253 2.31359 1.8258 0.6806
Total Extraordinary Items 0 1.226
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 1366.08 1356.8 1359.87 1336.22 1360.74
Revenue 1366.08 1356.8 1359.87 1336.22 1360.74
Cost of Revenue, Total 1071.36 1088.55 1041.7 1017.78 1034.9
Gross Profit 294.717 268.251 318.164 318.439 325.842
Total Operating Expense 1323.86 1396.34 1265.76 1218.45 1244.14
Selling/General/Admin. Expenses, Total 182.523 161.517 137.693 130.355 139.04
Depreciation / Amortization 59.332 61.587 62.242 61.514 61.221
Unusual Expense (Income) 10.641 84.687 24.124 8.794 8.983
Operating Income 42.221 -39.54 94.105 117.776 116.598
Interest Income (Expense), Net Non-Operating -40.719 -34.359 -51.796 -0.035 -13.362
Other, Net -0.841 -1.263 -1.605 -1.056 0.448
Net Income Before Taxes 0.661 -75.162 40.704 116.685 103.684
Net Income After Taxes 0.793 -72.149 55.528 87.049 77.744
Net Income Before Extra. Items 0.793 -72.149 55.528 87.049 77.744
Net Income 0.793 -72.149 55.528 87.049 77.744
Income Available to Common Excl. Extra. Items 0.793 -72.149 55.528 87.049 77.744
Income Available to Common Incl. Extra. Items 0.793 -72.149 55.528 87.049 77.744
Diluted Net Income 0.793 -72.149 55.528 87.049 77.744
Diluted Weighted Average Shares 104.344 103.326 103.219 103.206 103.072
Diluted EPS Excluding Extraordinary Items 0.0076 -0.69827 0.53796 0.84345 0.75427
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS 0.07389 -0.16552 0.68988 0.90702 0.81962
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 1943.94 1766.46 1738.01 1562.16 1491.96
Cash and Short Term Investments 112.004 106.475 272.173 163.689 155.932
Cash & Equivalents 112.004 106.475 272.173 163.689 155.932
Total Receivables, Net 1645.16 1524.89 1344.78 1303.64 1256.73
Accounts Receivable - Trade, Net 1645.16 1524.89 1344.78 1303.64 1256.73
Prepaid Expenses 186.77 135.091 121.058 94.679 77.944
Other Current Assets, Total 0.155 1.355
Total Assets 8199.22 8237.09 8063.31 7453.79 7254.91
Property/Plant/Equipment, Total - Net 437.089 432.065 439.485 422.457 183.486
Property/Plant/Equipment, Total - Gross 769.087 734.359 690.454 627.932 337.61
Accumulated Depreciation, Total -331.998 -302.294 -250.969 -205.475 -154.124
Goodwill, Net 4897.52 4956.02 4776.18 4350.38 4333.16
Intangibles, Net 680.863 854.067 933.525 973.081 1133.61
Other Long Term Assets, Total 239.812 228.49 176.106 145.713 112.69
Total Current Liabilities 1724.69 1654.12 1577.33 1516.46 1503.2
Accounts Payable 118.621 107.535 113.684 136.686 98.624
Accrued Expenses 643.584 654.102 648.797 569.051 548.451
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 24.011 20.627 17.455 75.902 63.906
Other Current Liabilities, Total 938.475 871.852 797.395 734.822 792.217
Total Liabilities 4704.22 4824.54 4821.19 4424.14 4398.77
Total Long Term Debt 2655.29 2809.9 2933.58 2587.31 2763.78
Long Term Debt 2611.17 2775.72 2902.05 2550.4 2737.02
Deferred Income Tax 92.155 78.062 20.216 11.101 25.12
Other Liabilities, Total 232.081 282.458 290.071 309.27 106.669
Total Equity 3495 3412.55 3242.11 3029.65 2856.14
Redeemable Preferred Stock 0 0
Common Stock 1.029 1.038 1.039 1.039 1.034
Additional Paid-In Capital 3460.15 3474.09 3461.75 3441.47 3402.64
Retained Earnings (Accumulated Deficit) 167.694 -12.953 -179.873 -341.263 -459.333
Other Equity, Total -133.874 -49.618 -40.801 -71.593 -88.195
Total Liabilities & Shareholders’ Equity 8199.22 8237.09 8063.31 7453.79 7254.91
Total Common Shares Outstanding 102.911 103.764 103.935 103.866 103.372
Capital Lease Obligations 44.124 34.181 31.522 36.914 26.759
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Total Current Assets 1946.28 1943.94 1963.21 1881.87 1876.26
Cash and Short Term Investments 111.055 112.004 170.1 105.988 119.151
Cash & Equivalents 111.055 112.004 170.1 105.988 119.151
Total Receivables, Net 1650.9 1645.16 1647.46 1606.95 1596.31
Accounts Receivable - Trade, Net 1650.9 1645.16 1647.46 1606.95 1596.31
Prepaid Expenses 184.32 186.77 145.645 168.932 160.792
Total Assets 8098.78 8199.22 8197.78 8216.67 8303.96
Property/Plant/Equipment, Total - Net 356.619 437.089 441.476 439.922 441.422
Goodwill, Net 4907.07 4897.52 4850.46 4898.05 4942.73
Intangibles, Net 644.843 680.863 710.637 759.436 808.931
Other Long Term Assets, Total 243.966 239.812 232.007 237.393 234.623
Total Current Liabilities 1687.9 1724.69 1723.34 1707.46 1722.38
Accounts Payable 145.967 118.621 118.952 99.319 108.315
Accrued Expenses 660.809 658.184 694.322 697.282 700.318
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 21.743 24.011 25.053 23.678 21.998
Other Current Liabilities, Total 859.381 923.875 885.013 887.18 891.75
Total Liabilities 4644.31 4704.22 4843.72 4887.61 5002.4
Total Long Term Debt 2650 2655.29 2802.93 2861.22 2946.43
Long Term Debt 2611.58 2611.17 2752.47 2811.83 2906.27
Capital Lease Obligations 38.421 44.124 50.463 49.389 40.162
Deferred Income Tax 74.903 92.155 82.284 82.519 78.609
Other Liabilities, Total 231.501 232.081 235.165 236.409 254.98
Total Equity 3454.47 3495 3354.06 3329.06 3301.56
Redeemable Preferred Stock 0 0 0
Common Stock 1.036 1.029 1.029 1.026 1.026
Additional Paid-In Capital 3482.61 3460.15 3449.4 3425.58 3410.52
Retained Earnings (Accumulated Deficit) 95.545 167.694 112.166 25.117 -52.627
Other Equity, Total -124.724 -133.874 -208.533 -122.662 -57.364
Total Liabilities & Shareholders’ Equity 8098.78 8199.22 8197.78 8216.67 8303.96
Total Common Shares Outstanding 103.641 102.911 102.895 102.647 102.558
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 266.497 234.831 192.787 131.258 24.284
Cash From Operating Activities 426.981 450.278 425.493 318.481 303.448
Cash From Operating Activities 247.179 235.625 222.352 242.465 273.685
Deferred Taxes -1.863 46.522 -3.839 -40.069 0.24
Non-Cash Items 41.886 70.447 55.883 77.887 8.983
Cash Taxes Paid 66.9 35.1 23.4 12.2 2.042
Cash Interest Paid 75.384 63.952 83.69 129.756 131.827
Changes in Working Capital -126.718 -137.147 -41.69 -93.06 -3.744
Cash From Investing Activities -105.634 -340.346 -504.084 -81.661 -145.485
Capital Expenditures -93.459 -56.841 -50.01 -63.973 -54.595
Other Investing Cash Flow Items, Total -12.175 -283.505 -454.074 -17.688 -90.89
Cash From Financing Activities -339.157 -277.577 178.265 -215.469 -319.356
Financing Cash Flow Items -37.625 -39.658 -57.424 -15.949 -29.523
Issuance (Retirement) of Stock, Net -126.256 -89.373 -45.583 -16.394 -53.164
Issuance (Retirement) of Debt, Net -175.276 -148.546 281.272 -183.126 -236.669
Foreign Exchange Effects 23.339 1.947 8.81 -13.594 -4.651
Net Change in Cash 5.529 -165.698 108.484 7.757 -166.044
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -72.149 266.497 210.969 123.92 46.176
Cash From Operating Activities 30.424 426.981 303.164 170.789 70.887
Cash From Operating Activities 61.587 247.179 184.937 123.423 62.202
Deferred Taxes -12.052 -1.863 8.797 4.206 1
Non-Cash Items 41.712 41.886 8.081 18.393 15.714
Changes in Working Capital 11.326 -126.718 -109.62 -99.153 -54.205
Cash From Investing Activities -27.622 -105.634 -79.547 -51.063 -25.497
Capital Expenditures -27.509 -93.459 -69.833 -47.912 -23.474
Other Investing Cash Flow Items, Total -0.113 -12.175 -9.714 -3.151 -2.023
Cash From Financing Activities 0.199 -339.157 -189.487 -134.519 -36.572
Financing Cash Flow Items -8.092 -37.625 -33.715 -30.062 -25.901
Issuance (Retirement) of Stock, Net 11.962 -126.256 -126.393 -137.571 -138.478
Issuance (Retirement) of Debt, Net -3.671 -175.276 -29.379 33.114 127.807
Foreign Exchange Effects -3.95 23.339 29.495 14.306 3.858
Net Change in Cash -0.949 5.529 63.625 -0.487 12.676

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

INC Research Company profile

About Syneos Health Inc

Syneos Health, Inc. is a biopharmaceutical solutions company. It provides a range of clinical and commercial services to customers in the pharmaceutical, biotechnology, and healthcare industries. It offers both stand-alone and integrated biopharmaceutical product development solutions ranging from Early Phase (Phase I) clinical trials to the full commercialization of biopharmaceutical products. It operates through two business segments: Clinical Solutions and Commercial Solutions. Clinical Solutions segment offers global services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics that span Phase I to IV of clinical development. The segment offers individual services including product development, project management, protocol development, investigational site recruitment, and clinical monitoring. The Commercial Solutions segment provides commercialization services, including deployment solutions, communication solutions, and consulting services.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Syneos Health Inc revenues increased 18% to $5.21B. Net income increased 22% to $234.8M. Revenues reflect Clinical Solutions segment increase of 21% to $4.01B, Commercial Solutions segment increase of 9% to $1.2B, North America segment increase of 13% to $3.14B, Europe, Middle East and Africa segment increase of 26% to $1.33B, Asia-Pacific segment increase of 28% to $594.2M.

Industry: Biotechnology & Medical Research (NEC)

1030 Sync Street
MORRISVILLE
NORTH CAROLINA 27560
US

Income Statement

  • Annual
  • Quarterly

News

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

Higher CPI leaves traders unfazed as US equities continue to build momentum

The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.

12:42, 15 March 2024

Four reasons why Bitcoin is surging to record highs

Bitcoin has surged to record highs. We discuss the four factors pushing Bitcoin higher and analyse the technicals of the cryptocurrency’s technicals.

10:18, 14 March 2024

China’s National People’s Congress: The markets have again been left wanting more

China’s National People’s Congress (NPC) is underway, and the markets have so far been disappointed by what’s been delivered by the country’s central government. We look at some of the significant takeaways from the event, discuss China’s current economic conditions, and analyse the China A50.

08:23, 8 March 2024
Facade on the Federal Reserve Building in Washington DC

Central Banks: which one will cut first?

Central banks dominate the calendar in March and markets try to anticipate which one will be the first one to cut

13:14, 6 March 2024

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

People also watch

Gold

2,210.01 Price
+0.690% 1D Chg, %
Long position overnight fee -0.0188%
Short position overnight fee 0.0106%
Overnight fee time 21:00 (UTC)
Spread 0.30

BTC/USD

70,848.60 Price
+2.790% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

XRP/USD

0.63 Price
+1.230% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

ETH/USD

3,573.88 Price
+1.710% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading